BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15650627)

  • 1. Detection of hematogenous tumor cell dissemination predicts tumor relapse in patients undergoing surgical resection of colorectal liver metastases.
    Taylor B
    Ann Surg; 2005 Feb; 241(2):206-7. PubMed ID: 15650627
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of hematogenous tumor cell dissemination predicts tumor relapse in patients undergoing surgical resection of colorectal liver metastases.
    Koch M; Kienle P; Hinz U; Antolovic D; Schmidt J; Herfarth C; von Knebel Doeberitz M; Weitz J
    Ann Surg; 2005 Feb; 241(2):199-205. PubMed ID: 15650626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disseminated tumor cells in the bone marrow negatively influence survival after resection of colorectal liver metastases.
    Hinz S; Bockhorst J; Röder C; Egberts JH; Schafmayer C; Küchler T; Becker T; Kalthoff H
    Ann Surg Oncol; 2012 Aug; 19(8):2539-46. PubMed ID: 22395998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of hematogenic tumor cell dissemination in patients undergoing resection of liver metastases of colorectal cancer.
    Weitz J; Koch M; Kienle P; Schrödel A; Willeke F; Benner A; Lehnert T; Herfarth C; von Knebel Doeberitz M
    Ann Surg; 2000 Jul; 232(1):66-72. PubMed ID: 10862197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of two different resection techniques (conventional liver resection versus anterior approach) of liver metastases from colorectal cancer on hematogenous tumor cell dissemination - prospective randomized multicenter trial.
    Schmidt T; Koch M; Antolovic D; Reissfelder C; Schmitz-Winnenthal FH; Rahbari NN; Schmidt J; Seiler CM; Büchler MW; Weitz J
    BMC Surg; 2008 Mar; 8():6. PubMed ID: 18321372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micrometastatic colorectal cancer lesions in the liver.
    Nanko M; Shimada H; Yamaoka H; Tanaka K; Masui H; Matsuo K; Ike H; Oki S; Hara M
    Surg Today; 1998; 28(7):707-13. PubMed ID: 9697263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative detection of circulating cancer cells in patients with colorectal hepatic metastases.
    Uchikura K; Ueno S; Takao S; Miyazono F; Nakashima S; Tokuda K; Nakajo A; Matsumoto M; Aiko T
    Hepatogastroenterology; 2002; 49(48):1611-4. PubMed ID: 12397747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrahepatic lymphatic invasion independently predicts poor survival and recurrences after hepatectomy in patients with colorectal carcinoma liver metastases.
    Jaeck D; Oussoultzoglou E
    Ann Surg Oncol; 2007 Dec; 14(12):3297-8. PubMed ID: 17899283
    [No Abstract]   [Full Text] [Related]  

  • 9. Profile of serum factors and disseminated tumor cells before and after radiofrequency ablation compared to resection of colorectal liver metastases - a pilot study.
    Hinz S; Tepel J; Röder C; Kalthoff H; Becker T
    Anticancer Res; 2015 May; 35(5):2961-7. PubMed ID: 25964582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recurrent colorectal liver metastases: who benefits from a second hepatic resection?].
    Konopke R; Volk A; Gastmeier J; Ehehalt F; Distler M; Saeger HD; Kersting S
    Zentralbl Chir; 2014 Apr; 139(2):226-34. PubMed ID: 23846538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.
    Margonis GA; Kim Y; Sasaki K; Samaha M; Amini N; Pawlik TM
    Cancer; 2016 Sep; 122(17):2698-707. PubMed ID: 27244540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of circulating angiogenic factors with circulating tumor cells and disease recurrence in patients undergoing curative resection for colorectal liver metastases.
    Rahbari NN; Reissfelder C; Mühlbayer M; Weidmann K; Kahlert C; Büchler MW; Weitz J; Koch M
    Ann Surg Oncol; 2011 Aug; 18(8):2182-91. PubMed ID: 21598056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? An update.
    Mulier S; Ruers T; Jamart J; Michel L; Marchal G; Ni Y
    Dig Surg; 2008; 25(6):445-60. PubMed ID: 19212117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAS Mutation is Associated with Unsalvageable Recurrence Following Hepatectomy for Colorectal Cancer Liver Metastases.
    Okuno M; Goumard C; Kopetz S; Vega EA; Joechle K; Mizuno T; Omichi K; Tzeng CD; Chun YS; Vauthey JN; Conrad C
    Ann Surg Oncol; 2018 Aug; 25(8):2457-2466. PubMed ID: 29786130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis and treatment of colorectal liver metastases - workflow].
    Grundmann RT; Hermanek P; Merkel S; Germer CT; Grundmann RT; Hauss J; Henne-Bruns D; Herfarth K; Hermanek P; Hopt UT; Junginger T; Klar E; Klempnauer J; Knapp WH; Kraus M; Lang H; Link KH; Löhe F; Merkel S; Oldhafer KJ; Raab HR; Rau HG; Reinacher-Schick A; Ricke J; Roder J; Schäfer AO; Schlitt HJ; Schön MR; Stippel D; Tannapfel A; Tatsch K; Vogl TJ;
    Zentralbl Chir; 2008 Jun; 133(3):267-84. PubMed ID: 18563694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver metastases from gastric cancer represent systemic disease in comparison with those from colorectal cancer.
    Oguro S; Imamura H; Yoshimoto J; Ishizaki Y; Kawasaki S
    J Hepatobiliary Pancreat Sci; 2016 Jun; 23(6):324-32. PubMed ID: 26946472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laparoscopic Resection for Recurrent Hepatic Colorectal Metastases.
    House MG
    Ann Surg; 2016 May; 263(5):e73. PubMed ID: 26720433
    [No Abstract]   [Full Text] [Related]  

  • 18. RAS Mutation Predicts Positive Resection Margins and Narrower Resection Margins in Patients Undergoing Resection of Colorectal Liver Metastases.
    Brudvik KW; Mise Y; Chung MH; Chun YS; Kopetz SE; Passot G; Conrad C; Maru DM; Aloia TA; Vauthey JN
    Ann Surg Oncol; 2016 Aug; 23(8):2635-43. PubMed ID: 27016292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Visceral Adiposity as Well as Sarcopenic Factors on Outcomes in Patients Undergoing Liver Resection for Colorectal Liver Metastases.
    Kobayashi A; Kaido T; Hamaguchi Y; Okumura S; Shirai H; Kamo N; Yagi S; Taura K; Okajima H; Uemoto S
    World J Surg; 2018 Apr; 42(4):1180-1191. PubMed ID: 28936708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detecting curable disease following hepatectomy for colorectal metastases.
    Metcalfe M; Mann C; Mullin E; Maddern G
    ANZ J Surg; 2005 Jul; 75(7):524-7. PubMed ID: 15972037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.